Open Access. Powered by Scholars. Published by Universities.®

Public Health Commons

Open Access. Powered by Scholars. Published by Universities.®

Edith Cowan University

2022

SARS-CoV-2

Articles 1 - 3 of 3

Full-Text Articles in Public Health

Characterization And Determinant Factors Of Critical Illness And In-Hospital Mortality Of Covid-19 Patients: A Retrospective Cohort Of 1,792 Patients In Kenya, Isinta M. Elijah, Endawoke Amsalu, Xuening Jian, Mingyang Cao, Eric K. Mibei, Danvas O. Kerosi, Francis G. Mwatsahu, Wei Wang, Faith Onyangore, Youxin Wang Oct 2022

Characterization And Determinant Factors Of Critical Illness And In-Hospital Mortality Of Covid-19 Patients: A Retrospective Cohort Of 1,792 Patients In Kenya, Isinta M. Elijah, Endawoke Amsalu, Xuening Jian, Mingyang Cao, Eric K. Mibei, Danvas O. Kerosi, Francis G. Mwatsahu, Wei Wang, Faith Onyangore, Youxin Wang

Research outputs 2022 to 2026

Limited data is available on the coronavirus disease 2019 (COVID-19), critical illness rate, and in-hospital mortality in the African setting. This study investigates determinants of critical illness and in-hospital mortality among COVID-19 patients in Kenya. We conducted a retrospective cohort study at Kenyatta National Hospital (KNH) in Kenya. Multivariate logistic regression and Cox proportional hazard regression were employed to determine predictor factors for intensive care unit (ICU) admission and in-hospital mortality, respectively. In addition, the Kaplan-Meier model was used to compare the survival times using log-rank tests. As a result, 346 (19.3 %) COVID-19 patients were admitted to ICU, and …


Travel Ban Effects On Sars-Cov-2 Transmission Lineages In The Uae As Inferred By Genomic Epidemiology, Andreas Henschel, Samuel F. Feng, Rifat A. Hamoudi, Gihan Daw Elbait, Ernesto Damiani, Fathimathuz Waasia, Guan K. Tay, Bassam H. Mahboub, Maimunah Hemayet Uddin, Juan Acuna, Eman Alefishat, Rabih Halwani, Herbert F. Jelinek, Farah Mustafa, Nawal Alkaabi, Habiba S. Alsafar Mar 2022

Travel Ban Effects On Sars-Cov-2 Transmission Lineages In The Uae As Inferred By Genomic Epidemiology, Andreas Henschel, Samuel F. Feng, Rifat A. Hamoudi, Gihan Daw Elbait, Ernesto Damiani, Fathimathuz Waasia, Guan K. Tay, Bassam H. Mahboub, Maimunah Hemayet Uddin, Juan Acuna, Eman Alefishat, Rabih Halwani, Herbert F. Jelinek, Farah Mustafa, Nawal Alkaabi, Habiba S. Alsafar

Research outputs 2022 to 2026

Global and local whole genome sequencing of SARS-CoV-2 enables the tracing of domestic and international transmissions. We sequenced Viral RNA from 37 sampled Covid-19 patients with RT-PCR-confirmed infections across the UAE and developed time-resolved phylogenies with 69 local and 3,894 global genome sequences. Furthermore, we investigated specific clades associated with the UAE cohort and, their global diversity, introduction events and inferred domestic and international virus transmissions between January and June 2020. The study comprehensively characterized the genomic aspects of the virus and its spread within the UAE and identified that the prevalence shift of the D614G mutation was due to …


Immune Response To Sars-Cov-2 Variants: A Focus On Severity, Susceptibility, And Preexisting Immunity, Eman Alefishat, Herbert F. Jelinek, Mira Mousa, Guan K. Tay, Habiba S. Alsafar Feb 2022

Immune Response To Sars-Cov-2 Variants: A Focus On Severity, Susceptibility, And Preexisting Immunity, Eman Alefishat, Herbert F. Jelinek, Mira Mousa, Guan K. Tay, Habiba S. Alsafar

Research outputs 2022 to 2026

The heterogeneous phenotypes among patients with coronavirus disease 2019 (COVID-19) has drawn worldwide attention, especially those with severe symptoms without comorbid conditions. Immune responses to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causative virus of COVID-19, occur mainly by the innate immune response via the interferon (IFN)-mediated pathways, and the adaptive immunity via the T lymphocyte and the antibody mediated pathways. The ability of the original Wuhan SARS-CoV-2 strain, and possibly more so with new emerging variants, to antagonize IFN-mediated antiviral responses can be behind the higher early viral load, higher transmissibility, and milder symptoms compared to SARS-CoV and are …